Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The direct answer, and the regulatory stack you are actually building against
Operators build a behavioral health compliance program by taking the HHS Office of Inspector General’s Seven Elements and operationalizing them against the specific stack that governs this industry: 42 CFR Part 2, HIPAA, state licensure, accreditation standards from The Joint Commission or CARF International, and payer contract terms. A functional program pairs a written plan and a designated Compliance Officer with ongoing auditing, workforce training, enforced discipline, and documented corrective action. Everything else is decoration.
The baseline document is the OIG General Compliance Program Guidance, which the agency released on November 6, 2023. That was the first full update in more than 15 years, and it reorganizes the historic seven elements with a deeper discussion of each while staying agnostic to the facility type. The elements themselves: written policies and procedures; compliance leadership and oversight; training and education; effective lines of communication with the compliance officer and disclosure programs; enforcing standards, consequences and incentives; risk assessment, auditing and monitoring; and responding to detected offenses and developing corrective action initiatives.
For a behavioral health operator in Florida, Texas, or New Jersey, those seven elements have to answer to the Florida Department of Children and Families, Texas HHSC, and the New Jersey Division of Mental Health and Addiction Services at the state level, plus SAMHSA and the Center for Substance Abuse Treatment at the federal level. If your written plan does not name those regulators and connect their rules to a specific SOP owned by a specific person on your org chart, you do not have a compliance program. You have a binder.
What the OIG, OCR, and DOJ numbers tell you about where enforcement is actually landing
Private-equity buyers I talk to want to know where the bodies are buried before they wire the check. The DOJ numbers tell you. In Fiscal Year 2024, False Claims Act recoveries exceeded $2.9 billion, approximately $1.7 billion of which involved the health care industry. That same year saw the highest number of qui tam actions filed in a single year at 979 lawsuits. The whistleblower is almost always a former employee: a biller, a UR nurse, a tech, a marketing rep who was told to do something they knew was wrong.
On the privacy side, the Office for Civil Rights now has delegated enforcement authority for 42 CFR Part 2, with a compliance deadline of February 16, 2026. The penalty structure for violating Part 2 now mirrors HIPAA’s penalty structure. Translation: the SUD confidentiality rule that used to generate letters from SAMHSA now generates resolution agreements, corrective action plans, and civil money penalties from the same OCR that runs the HIPAA breach portal. Operators who ran Part 2 as a side policy with no real enforcement risk no longer have that luxury.
As one healthcare attorney put it recently, “A healthcare compliance program is judged less by what its policy manual says than by what its records prove it did.” Auditors, prosecutors, and acquirers all ask the same question: show me the evidence file. The 2024 OIG CPG update makes that explicit. If you cannot produce the risk assessment, the audit workpapers, the training rosters with signatures, the LEIE screens, the disciplinary records, and the corrective action logs on demand, you do not get credit for the program at all.
Mapping the Seven Elements to behavioral health workflows: intake, UR, billing, marketing, lab
Here is where most generic compliance content falls apart. SimiTree and C4 will tell you the Seven Elements exist. They will not tell you what element 6, risk assessment and auditing, actually looks like when a Texas HHSC surveyor walks into a 60-bed residential program on a Tuesday morning. Below is how we map it at AHS.
- Intake and admissions. Written policies tie ASAM Criteria 4th Edition level-of-care determinations to the clinician who signs them. Mock chart audits sample 10% of admissions monthly against medical necessity criteria written into the payer contract. 42 CFR Part 2 consent forms get updated to the single-TPO-consent format allowed under the 2024 Final Rule.
- Utilization review. The UR nurse reports functionally to the Compliance Officer on documentation integrity, not just to the Clinical Director on length of stay. Concurrent review notes have to match the ASAM dimensions in the chart. If they do not match, that is a finding before any SIU audit catches it.
- Billing and revenue integrity. Monthly audits sample claims against the clinical note, the authorization, and the fee schedule. Modifier use, place-of-service codes for PHP (Level 2.5, outpatient), and timely filing all get tracked. Payer takeback letters route to the Compliance Officer, not just to the billing manager.
- Marketing, call centers, and lab. This is the EKRA zone. Every marketer contract, every call-center per-admit arrangement, every lab marketing agreement gets reviewed against 18 U.S.C. § 220 and the Anti-Kickback Statute before it is signed, not after a subpoena lands.
- Workforce. Every employee, contractor, and referral source gets screened against the OIG List of Excluded Individuals/Entities. OIG updates the LEIE monthly, which is why a check performed only at hire leaves the file stale within weeks.
The 2024 Part 2 Final Rule also forces practical SOP changes most programs have not made yet. The rule now permits a single consent for all future uses and disclosures of Part 2 records for TPO, and aligns the required consent elements with HIPAA authorization requirements. Previously, only Part 2 Programs that were also HIPAA regulated entities were required to report breaches under the HIPAA Breach Notification Rule. Under the Final Rule, Part 2 Programs must report all breaches according to the HIPAA Breach Notification Rule. If your Notice of Privacy Practices, your consent forms, and your breach SOP still look like they did in 2023, you are already behind.
Year-one work plan, governance cadence, and the accreditation overlay
A credible year-one work plan has to produce evidence, not activity. Here is the sequence I give operators in Montana, Texas, Florida, and New Jersey when they ask what the first twelve months look like.
- Days 1 to 30. Appoint the Compliance Officer in writing with a job description, board resolution, and a reporting line that does not run through the General Counsel or the CFO. The arrangement most often questioned is a compliance officer reporting into the general counsel, because it collapses exactly the separation the guidance asks for. Charter the Compliance Committee. Set the quarterly board reporting cadence.
- Days 31 to 90. Complete a documented risk assessment covering HIPAA, Part 2, EKRA, AKS, False Claims Act exposure, DEA registration and Ryan Haight Act (if you prescribe MAT via telehealth), state licensure, and payer contract terms. Rank the risks. Pick the top ten for the year-one work plan.
- Days 91 to 180. Rewrite policies and procedures to reflect the 2024 Part 2 Final Rule. Roll out workforce training with signed attestations. Run the first mock chart audit sample. Begin the EOC tour pre-work for your Joint Commission or CARF survey window.
- Days 181 to 365. Internal audits on billing, UR documentation, intake consent, marketing contracts, and LEIE screening. Quarterly Compliance Committee minutes. One tabletop exercise on breach response. One full mock survey against the accreditor’s current standards. Documented corrective action for every finding.
On the market-size question operators always ask: 2024 was a record-breaking year for whistleblower cases filed under the False Claims Act. There were 979 whistleblower filings allowing the Department of Justice to recover $2.4 billion. DOJ False Claims Act settlements in 2024 pulled in a total of $2.9 billion, $1.67 billion of which was attributed to healthcare. If you are a PE-backed buyer running diligence on a treatment-center platform, those are the numbers behind the compliance representations in the purchase agreement.
Frequently asked questions
What are the OIG’s Seven Elements of an Effective Compliance Program and how do they apply to behavioral health?
The elements are written policies and procedures, compliance leadership and oversight, training and education, effective lines of communication with the Compliance Officer, enforcing standards through consequences and incentives, risk assessment and auditing and monitoring, and responding to detected offenses with corrective action. In behavioral health, each one has to be mapped against 42 CFR Part 2, HIPAA, state licensure (Florida DCF, Texas HHSC, New Jersey DMHAS, Montana), accreditation standards from The Joint Commission or CARF, EKRA, and the Anti-Kickback Statute. The written plan is useless until a named person owns the SOP behind each element.
Do I need a dedicated Compliance Officer or can my Clinical Director serve dual-role?
Small operators can combine roles under the OIG’s own small-entity adaptations, but the reporting line matters more than the headcount. If facility compliance officers have other roles at their locations, they should have dotted-line reporting to the compliance officer, and the compliance officer should make sure each facility compliance officer has the skills, knowledge, resources, and time to fulfill his or her compliance duties. A Clinical Director reporting to a CEO who also owns clinical outcomes is a conflict I would never pass through diligence. Once you are at roughly 100 beds across sites or $20M in net revenue, carve the role out.
How does 42 CFR Part 2 compliance differ from HIPAA for an SUD program?
Part 2 still requires patient consent before disclosing SUD records in situations where HIPAA would allow a TPO disclosure without authorization. Even after the 2024 alignment, Part 2 still generally requires patient consent before disclosing SUD treatment records, while HIPAA permits many treatment, payment, and operations disclosures without separate patient authorization. The 2024 rule simplified Part 2 consent to a single form covering future TPO uses, but it did not remove the underlying consent requirement. The practical change in 2024: breach notification, patient notice, and enforcement penalties now mirror HIPAA, and OCR runs the enforcement.
What should a behavioral health compliance work plan include in year one?
A written Compliance Officer appointment and Committee charter, a documented risk assessment, updated policies that reflect the 2024 Part 2 Final Rule, workforce training with signed attestations, monthly LEIE screening, quarterly internal audits of intake, UR, billing, and marketing contracts, a breach-response tabletop, a mock survey against your accreditor’s current standards, and documented corrective action for every finding. Board-level reporting at least quarterly. Keep the evidence file. The file is the program.
How do EKRA and the Anti-Kickback Statute change how I structure marketing, call centers, and lab relationships?
EKRA, codified at 18 U.S.C. § 220, criminalizes paying or receiving remuneration to induce referrals to recovery homes, clinical treatment facilities, or labs, and it applies to all payers, not just federal programs. That means per-admit marketing fees, percentage-of-collections call-center arrangements, and lab marketing deals that would have been structured around AKS safe harbors can still be EKRA violations. For PE-backed platforms, that risk sits in diligence, in the purchase agreement reps, and in the post-close integration of any acquired marketing or lab arrangement. Every one of those contracts gets a legal review before it is signed.
References
- HHS Office of Inspector General, General Compliance Program Guidance (November 2023)
- Federal Register: Confidentiality of Substance Use Disorder (SUD) Patient Records Final Rule (February 16, 2024)
- HIPAA Journal: February 16, 2026 Compliance Deadline for Part 2 Final Rule
- Baker Donelson: HHS Announces OCR Enforcement Authority for Part 2 Final Rule
- Morrison Foerster: DOJ Announces $2.92 Billion in False Claims Act Recoveries in Fiscal Year 2024
- Holland & Knight: DOJ Publishes FY 2024 False Claims Act Statistics
- McDermott Will & Emery: OIG Issues General Compliance Program Guidance Updates